The in vitro multilineage differentiation and maturation of lung and airway cells from human pluripotent stem cell-derived lung progenitors in 3D.


Journal

Nature protocols
ISSN: 1750-2799
Titre abrégé: Nat Protoc
Pays: England
ID NLM: 101284307

Informations de publication

Date de publication:
04 2021
Historique:
received: 25 03 2019
accepted: 26 11 2020
pubmed: 3 3 2021
medline: 5 5 2021
entrez: 2 3 2021
Statut: ppublish

Résumé

Lung and airway epithelial cells generated in vitro from human pluripotent stem cells (hPSCs) have applications in regenerative medicine, modeling of lung disease, drug screening and studies of human lung development. Here, we describe a strategy for directed differentiation of hPSCs into mature lung and airway epithelial cells obtained through maturation of NKX2.1

Identifiants

pubmed: 33649566
doi: 10.1038/s41596-020-00476-z
pii: 10.1038/s41596-020-00476-z
pmc: PMC9460941
mid: NIHMS1780599
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1802-1829

Subventions

Organisme : NCRR NIH HHS
ID : S10 RR027050
Pays : United States
Organisme : NIAID NIH HHS
ID : R56 AI031971
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI114736
Pays : United States
Organisme : NIH HHS
ID : S10 OD020056
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL134760
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL120046
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI031971
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL142727
Pays : United States

Références

Green, M. D., Huang, S. X. L. & Snoeck, H. W. Stem cells of the respiratory system: from identification to differentiation into functional epithelium. BioEssays 35, 261–270 (2013).
pubmed: 23175215 doi: 10.1002/bies.201200090
Green, M. D. et al. Generation of anterior foregut endoderm from human embryonic and induced pluripotent stem cells. Nat. Biotechnol. 29, 267–272 (2011).
pubmed: 21358635 pmcid: 4866999 doi: 10.1038/nbt.1788
Mou, H. et al. Generation of multipotent lung and airway progenitors from mouse ESCs and patient-specific cystic fibrosis iPSCs. Cell Stem Cell 10, 385–397 (2012).
pubmed: 22482504 pmcid: 3474327 doi: 10.1016/j.stem.2012.01.018
Wong, A. P. et al. Directed differentiation of human pluripotent stem cells into mature airway epithelia expressing functional CFTR protein. Nat. Biotechnol. 30, 876–882 (2012).
pubmed: 22922672 pmcid: 3994104 doi: 10.1038/nbt.2328
Huang, S. X. L. et al. Efficient generation of lung and airway epithelial cells from human pluripotent stem cells. Nat. Biotechnol. 32, 84–91 (2014).
pubmed: 24291815 doi: 10.1038/nbt.2754
Firth, A. L. et al. Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells. Proc. Natl Acad. Sci. USA 111, E1723–E1730 (2014).
pubmed: 24706852 doi: 10.1073/pnas.1403470111
Gotoh, S. et al. Generation of alveolar epithelial spheroids via isolated progenitor cells from human pluripotent stem cells. Stem Cell Rep. 3, 394–403 (2014).
doi: 10.1016/j.stemcr.2014.07.005
Konishi, S. et al. Directed induction of functional multi-ciliated cells in proximal airway epithelial spheroids from human pluripotent stem cells. Stem Cell Rep. 6, 18–25 (2016).
doi: 10.1016/j.stemcr.2015.11.010
Chen, Y.-W. et al. A three-dimensional model of human lung development and disease from pluripotent stem cells. Nat. Cell Biol. 19, 542–549 (2017).
pubmed: 28436965 pmcid: 5777163 doi: 10.1038/ncb3510
McCauley, K. B. et al. Efficient derivation of functional human airway epithelium from pluripotent stem cells via temporal regulation of Wnt signaling. Cell Stem Cell 20, 844–857.e6 (2017).
pubmed: 28366587 pmcid: 5457392 doi: 10.1016/j.stem.2017.03.001
Jacob, A. et al. Differentiation of human pluripotent stem cells into functional lung alveolar epithelial cells. Cell Stem Cell 21, 472–488.e10 (2017).
pubmed: 28965766 pmcid: 5755620 doi: 10.1016/j.stem.2017.08.014
Yamamoto, Y. et al. Long-term expansion of alveolar stem cells derived from human iPS cells in organoids. Nat. Methods 14, 1097–1106 (2017).
pubmed: 28967890 doi: 10.1038/nmeth.4448
de Carvalho, A. L. R. T. et al. Glycogen synthase kinase 3 induces multilineage maturation of human pluripotent stem cell-derived lung progenitors in 3D culture. Development 146, dev171652 (2019).
pubmed: 30578291 pmcid: 6361135
Dye, B. R. et al. In vitro generation of human pluripotent stem cell derived lung organoids. eLife 4, e05098 (2015).
pmcid: 4370217 doi: 10.7554/eLife.05098
Miller, A. J. et al. Generation of lung organoids from human pluripotent stem cells in vitro. Nat. Protoc. 14, 518–540 (2019).
pubmed: 30664680 pmcid: 6531049 doi: 10.1038/s41596-018-0104-8
Dye, B. R., Miller, A. J. & Spence, J. R. How to grow a lung: applying principles of developmental biology to generate lung lineages from human pluripotent stem cells. Curr. Pathobiol. Rep. 4, 47–57 (2016).
pubmed: 27340610 pmcid: 4882378 doi: 10.1007/s40139-016-0102-x
Hawkins, F. & Kotton, D. N. Embryonic and induced pluripotent stem cells for lung regeneration. Ann. Am. Thorac. Soc. 12, S50–S53 (2015).
pubmed: 25830836 doi: 10.1513/AnnalsATS.201410-457MG
Swarr, D. T. & Morrisey, E. E. Lung endoderm morphogenesis: gasping for form and function. Annu. Rev. Cell Dev. Biol. 31, 553–573 (2015).
pubmed: 26359777 pmcid: 5051950 doi: 10.1146/annurev-cellbio-100814-125249
Huang, S. X. L. et al. The in vitro generation of lung and airway progenitor cells from human pluripotent stem cells. Nat. Protoc. 10, 413–425 (2015).
pubmed: 25654758 pmcid: 4654940 doi: 10.1038/nprot.2015.023
Rock, J. R. et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl Acad. Sci. USA 106, 12771–12775 (2009).
pubmed: 19625615 doi: 10.1073/pnas.0906850106
Hawkins, F. et al. Prospective isolation of NKX2-1–expressing human lung progenitors derived from pluripotent stem cells. J. Clin. Invest 127, 2277–2294 (2017).
pubmed: 28463226 pmcid: 5451263 doi: 10.1172/JCI89950
Strikoudis, A. et al. Modeling of fibrotic lung disease using 3D organoids derived from human pluripotent stem cells. Cell Rep. 27, 3709–3723.e5 (2019).
pubmed: 31216486 pmcid: 6594401 doi: 10.1016/j.celrep.2019.05.077
Dye, B. R. et al. A bioengineered niche promotes in vivo engraftment and maturation of pluripotent stem cell derived human lung organoids. eLife 5, e19732 (2016).
pubmed: 27677847 pmcid: 5089859 doi: 10.7554/eLife.19732
Butler, C. R. et al. Rapid expansion of human epithelial stem cells suitable for airway tissue engineering. Am. J. Respir. Crit. Care Med 194, 156–168 (2016).
pubmed: 26840431 pmcid: 5003214 doi: 10.1164/rccm.201507-1414OC
Ramani, S., Crawford, S. E., Blutt, S. E. & Estes, M. K. Human organoid cultures: transformative new tools for human virus studies. Curr. Opin. Virol. 29, 79–86 (2018).
pubmed: 29656244 pmcid: 5944856 doi: 10.1016/j.coviro.2018.04.001
Ciancanelli, M. J. et al. Infectious disease. Life-threatening influenza and impaired interferon amplification in human IRF7 deficiency. Science 348, 448–453 (2015).
pubmed: 25814066 pmcid: 4431581 doi: 10.1126/science.aaa1578
Rafeeq, M. M. & Murad, H. A. S. Cystic fibrosis: current therapeutic targets and future approaches. J. Transl. Med. 15, 84 (2017).
pubmed: 28449677 pmcid: 5408469 doi: 10.1186/s12967-017-1193-9
Kaur, A., Mathai, S. K. & Schwartz, D. A. Genetics in idiopathic pulmonary fibrosis pathogenesis, prognosis, and treatment. Front. Med 4, 154 (2017).
doi: 10.3389/fmed.2017.00154
Whitsett, J. A., Wert, S. E. & Weaver, T. E. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu. Rev. Med 61, 105–119 (2010).
pubmed: 19824815 pmcid: 4127631 doi: 10.1146/annurev.med.60.041807.123500
Kim, C. F. B. et al. Identification of bronchioalveolar stem cells in normal lung and lung. cancer Cell 121, 823–835 (2005).
Xu, X. et al. Evidence for type II cells as cells of origin of K-Ras-induced distal lung adenocarcinoma. Proc. Natl Acad. Sci. USA 109, 4910–4915 (2012).
pubmed: 22411819 doi: 10.1073/pnas.1112499109
Chen, H. J. et al. Generation of pulmonary neuroendocrine cells and SCLC-like tumors from human embryonic stem cells. J. Exp. Med 216, 674–687 (2019).
pubmed: 30737256 pmcid: 6400536 doi: 10.1084/jem.20181155
Chen, Z. et al. Genetic engineering of human embryonic stem cells for precise cell fate tracing during human lineage development. Stem Cell Rep. 11, 1257–1271 (2018).
doi: 10.1016/j.stemcr.2018.09.014
An, W. F. et al. Discovery of Potent and Highly Selective Inhibitors of GSK3b (National Center for Biotechnology Information, 2010).
Gonzales, L. W., Guttentag, S. H., Wade, K. C., Postle, A. D. & Ballard, P. L. Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP. Am. J. Physiol. Lung Cell. Mol. Physiol. 283, L940–L951 (2002).
pubmed: 12376347 doi: 10.1152/ajplung.00127.2002
Hynds, R. E., Butler, C. R., Janes, S. M. & Giangreco, A. Expansion of human airway basal stem cells and their differentiation as 3D tracheospheres. Methods Mol. Biol. 1576, 43–53 (2019).
pubmed: 27539459 doi: 10.1007/7651_2016_5
Gonzalez, R. F., Allen, L., Gonzales, L., Ballard, P. L. & Dobbs, L. G. HTII-280, a biomarker specific to the apical plasma membrane of human lung alveolar type II cells. J. Histochem. Cytochem. 58, 891–901 (2010).
pubmed: 20566753 pmcid: 2942742 doi: 10.1369/jhc.2010.956433
Barkauskas, C. E. et al. Type 2 alveolar cells are stem cells in adult lung. J. Clin. Invest 123, 3025–3036 (2013).
pubmed: 23921127 pmcid: 3696553 doi: 10.1172/JCI68782
Dobbs, L. G., Gonzalez, R. F., Allen, L. & Froh, D. K. HTI 56, an integral membrane protein specific to human alveolar type I cells. J. Histochem. Cytochem 47, 129–137 (1999).
pubmed: 9889249 doi: 10.1177/002215549904700202
Jarrard, J. A. et al. MUC1 is a novel marker for the type II pneumocyte lineage during lung carcinogenesis. Cancer Res 58, 5582–5589 (1998).
pubmed: 9850098
Ramirez, M. I. et al. T1α, a lung type I cell differentiation gene, is required for normal lung cell proliferation and alveolus formation at birth. Dev. Biol. 256, 62–73 (2003).
doi: 10.1016/S0012-1606(02)00098-2
Rock, J. R. et al. Notch-dependent differentiation of adult airway basal stem cells. Cell Stem Cell 8, 639–648 (2011).
pubmed: 21624809 pmcid: 3778678 doi: 10.1016/j.stem.2011.04.003
Kim, K. C. & Lillehoj, E. P. MUC1 mucin: a peacemaker in the lung. Am. J. Respir. Cell Mol. Biol. 39, 644–647 (2008).
pubmed: 18617677 pmcid: 2586042 doi: 10.1165/rcmb.2008-0169TR
McCauley, K. B. et al. Single-cell transcriptomic profiling of pluripotent stem cell-derived SCGB3A2+ airway epithelium. Stem Cell Rep. 10, 1579–1595 (2018).
doi: 10.1016/j.stemcr.2018.03.013
Roost, M. S. et al. KeyGenes, a tool to probe tissue differentiation using a human fetal transcriptional atlas. Stem Cell Rep. 4, 1112–1124 (2015).
doi: 10.1016/j.stemcr.2015.05.002
Lindahl, M., Ståhlbom, B. & Tagesson, C. Newly identified proteins in human nasal and bronchoalveolar lavage fluids: potential biomedical and clinical applications. Electrophoresis 20, 3670–3676 (1999).
pubmed: 10612294 doi: 10.1002/(SICI)1522-2683(19991201)20:18<3670::AID-ELPS3670>3.0.CO;2-Z
Porotto, M. et al. Authentic modeling of human respiratory virus infection in human pluripotent stem cell-derived lung organoids. mBio 10, e00723-19 (2019).
pubmed: 31064833 pmcid: 6509192 doi: 10.1128/mBio.00723-19
Branche, A. & Falsey, A. Parainfluenza virus infection. Semin. Respir. Crit. Care Med 37, 538–554 (2016).
pubmed: 27486735 pmcid: 7171724 doi: 10.1055/s-0036-1584798
Henrickson, K. J. Parainfluenza viruses. Clin. Microbiol. Rev. 16, 242–264 (2003).
pubmed: 12692097 pmcid: 153148 doi: 10.1128/CMR.16.2.242-264.2003
Schomacker, H., Schaap-Nutt, A., Collins, P. L. & Schmidt, A. C. Pathogenesis of acute respiratory illness caused by human parainfluenza viruses. Curr. Opin. Virol. 2, 294–299 (2012).
pubmed: 22709516 pmcid: 3514439 doi: 10.1016/j.coviro.2012.02.001
Zhang, L. et al. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. J. Virol. 79, 1113–1124 (2005).
pubmed: 15613339 pmcid: 538579 doi: 10.1128/JVI.79.2.1113-1124.2005

Auteurs

Ana Luisa Rodrigues Toste de Carvalho (AL)

Columbia Center for Human Development, Columbia University Medical Center, New York, NY, USA.
Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
ICVS/3B's, PT Government Associate Laboratory, Guimarães, Portugal.

Hsiao-Yun Liu (HY)

Columbia Center for Human Development, Columbia University Medical Center, New York, NY, USA.
Department of Medicine, Columbia University Medical Center, New York, NY, USA.

Ya-Wen Chen (YW)

Columbia Center for Human Development, Columbia University Medical Center, New York, NY, USA.
Department of Medicine, Columbia University Medical Center, New York, NY, USA.

Matteo Porotto (M)

Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, NY, USA.
Department of Experimental Medicine, University of Campania 'Luigi Vanvitelli', Caserta, Italy.

Anne Moscona (A)

Department of Pediatrics, Columbia University Medical Center, New York, NY, USA.
Center for Host-Pathogen Interaction, Columbia University Medical Center, New York, NY, USA.
Department of Microbiology & Immunology, Columbia University Medical Center, New York, NY, USA.
Department of Physiology & Cellular Biophysics, Columbia University Medical Center, New York, NY, USA.

Hans-Willem Snoeck (HW)

Columbia Center for Human Development, Columbia University Medical Center, New York, NY, USA. hs2680@columbia.edu.
Department of Medicine, Columbia University Medical Center, New York, NY, USA. hs2680@columbia.edu.
Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY, USA. hs2680@columbia.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH